Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Thomson Medical GroupFRA:3H5 EV-to-EBITDA is 37.06 as of Aug. 29, 2026, which is 6% above its 10-year median of 34.81. The stock has 7 warning signs investors should review. Among 517 Healthcare Providers & Services companies, Thomson Medical Group ranks worse than 91.68% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Thomson Medical Group's enterprise value is €1,707.0 Mil.
Thomson Medical Group's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was €46.1 Mil. Therefore, Thomson Medical Group's EV-to-EBITDA for today is 37.06.
The historical rank and industry rank for Thomson Medical Group's EV-to-EBITDA or its related term are showing as below:
FRA:3H5'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -30.54 Med: 34.81 Max: 64.5
Current: 36.6
During the past 13 years, the highest EV-to-EBITDA of Thomson Medical Group was 64.50. The lowest was -30.54. And the median was 34.81.
FRA:3H5's EV-to-EBITDA is ranked worse than 91.68% of 517
companies
in the Healthcare Providers & Services industry
Industry Median: 10.49
vs FRA:3H5: 36.60
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Thomson Medical Group (FRA:3H5) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Thomson Medical Group's PE Ratio (TTM) for today is calculated as:
Thomson Medical Group's share price for today is €0.035.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Thomson Medical Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 was €-0.001.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
Thomson Medical Group EV-to-EBITDA Historical Data
* Premium members only.
The historical data trend for Thomson Medical Group's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Thomson Medical Group's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Thomson Medical Group EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Thomson Medical Group's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Thomson Medical Group's EV-to-EBITDA falls into.
Thomson Medical Group's current Enterprise Value is €1,707.0 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Thomson Medical Group's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was €46.1 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thomson Medical Group (FRA:3H5) has a EV-to-EBITDA of 37.06 as of Aug. 29, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Thomson Medical Group. This is near median its historical median of 34.81. According to the industry distribution chart, Thomson Medical Group ranks #474 out of 517 companies in the Healthcare Providers & Services industry, placing it in the top 91.7%.
Is Thomson Medical Group's EV-to-EBITDA too high?
Thomson Medical Group's current EV-to-EBITDA of 37.06 is near median its 10-year median of 34.81. The Healthcare Providers & Services industry median EV-to-EBITDA is 10.49. Thomson Medical Group's value of 37.06 is 253.3% above this industry median. Based on the distribution chart, Thomson Medical Group ranks #474 out of 517 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does Thomson Medical Group's EV-to-EBITDA compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Thomson Medical Group ranks #474 out of 517 companies for EV-to-EBITDA. This places Thomson Medical Group in the lower half of its industry. The industry median EV-to-EBITDA is 10.49. Thomson Medical Group's value of 37.06 is 253.3% above this benchmark. While the company's 10-year median is 34.81 vs. the industry median of 10.49, Thomson Medical Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 10.49, based on 517 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Thomson Medical Group's current EV-to-EBITDA of 37.06 is 253.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Thomson Medical Group. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 10.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Thomson Medical Group's current EV-to-EBITDA is 37.06, which is near median its own 10-year median of 34.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Thomson Medical Group stock overvalued right now?
Thomson Medical Group (FRA:3H5) has a current EV-to-EBITDA of 37.06. The stock's GF Value™ is €0.04, compared to a current price of €0.04 — trading 12.5% below its estimated fair value. The current EV-to-EBITDA is 37.06, which is near median its 10-year median of 34.81 and 253.3% above the Healthcare Providers & Services industry median of 10.49. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Thomson Medical Group (FRA:3H5), the current EV-to-EBITDA is 37.06 as of Aug. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Thomson Medical Group Ltd is a provider of healthcare services for women and children. Its segments include Hospital services; Specialised services and Investment holdings. It generates maximum revenue from the Specialised services segment. The specialised services segment includes services provided by fertility clinics, paediatric centres, cancer centre, cardiology centre, Chinese medicine, specialist skin centre and a pre-natal and clinical diagnostic laboratory and project-related services such as managing vaccination centres, COVID-19 Treatment Facilities and Transitional Care Facilities. It also includes a consumer business segment, comprising products and services. Geographically, it derives a majority of its revenue from Singapore.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:3H5 has been successfully added to your 
